<DOC>
	<DOCNO>NCT00371007</DOCNO>
	<brief_summary>A clinical study determine safety efficacy MK-0431 patient Type 2 diabetes mellitus inadequate glycemic control diet/exercise therapy</brief_summary>
	<brief_title>MK-0431 Early Phase II Double-blind Study - Type 2 Diabetes Mellitus ( 0431-043 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Patients type 2 diabetes mellitus On diet/exercise therapy Patients type 1 diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>